sentenceid,sentence_text,drug_pair,ddi_label,drug1,drug2,drug1offset,drug2offset,drugsinsent
DDI-DrugBank.d519.s3,Laboratory Tests Response to Plenaxis should be monitored by measuring serum total testosterone concentrations just prior to administration on Day 29 and every 8 weeks thereafter.,DDI-DrugBank.d519.s3.p0,0,Plenaxis,testosterone,29-36,83-94,"Plenaxis,testosterone,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p0,0,MTX,NSAIDs,50-52,55-60,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p1,0,MTX,corticosteroids,50-52,63-77,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p2,0,MTX,TNF blocking agents,50-52,84-102,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p3,0,MTX,abatacept,50-52,122-130,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p4,0,NSAIDs,corticosteroids,55-60,63-77,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p5,0,NSAIDs,TNF blocking agents,55-60,84-102,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p6,0,NSAIDs,abatacept,55-60,122-130,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p7,0,corticosteroids,TNF blocking agents,63-77,84-102,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p8,0,corticosteroids,abatacept,63-77,122-130,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s1,"Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.",DDI-DrugBank.d297.s1.p9,0,TNF blocking agents,abatacept,84-102,122-130,"MTX,NSAIDs,corticosteroids,TNF blocking agents,abatacept,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p0,0,ORENCIA,MTX,115-121,124-126,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p1,0,ORENCIA,NSAIDs,115-121,129-134,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p2,0,ORENCIA,corticosteroids,115-121,137-151,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p3,0,ORENCIA,TNF blocking agents,115-121,154-172,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p4,0,ORENCIA,azathioprine,115-121,175-186,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p5,0,ORENCIA,chloroquine,115-121,189-199,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p6,0,ORENCIA,gold,115-121,202-205,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p7,0,ORENCIA,hydroxychloroquine,115-121,208-225,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p8,0,ORENCIA,leflunomide,115-121,228-238,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p9,0,ORENCIA,sulfasalazine,115-121,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p10,0,ORENCIA,anakinra,115-121,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p11,0,MTX,NSAIDs,124-126,129-134,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p12,0,MTX,corticosteroids,124-126,137-151,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p13,0,MTX,TNF blocking agents,124-126,154-172,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p14,0,MTX,azathioprine,124-126,175-186,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p15,0,MTX,chloroquine,124-126,189-199,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p16,0,MTX,gold,124-126,202-205,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p17,0,MTX,hydroxychloroquine,124-126,208-225,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p18,0,MTX,leflunomide,124-126,228-238,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p19,0,MTX,sulfasalazine,124-126,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p20,0,MTX,anakinra,124-126,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p21,0,NSAIDs,corticosteroids,129-134,137-151,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p22,0,NSAIDs,TNF blocking agents,129-134,154-172,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p23,0,NSAIDs,azathioprine,129-134,175-186,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p24,0,NSAIDs,chloroquine,129-134,189-199,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p25,0,NSAIDs,gold,129-134,202-205,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p26,0,NSAIDs,hydroxychloroquine,129-134,208-225,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p27,0,NSAIDs,leflunomide,129-134,228-238,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p28,0,NSAIDs,sulfasalazine,129-134,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p29,0,NSAIDs,anakinra,129-134,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p30,0,corticosteroids,TNF blocking agents,137-151,154-172,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p31,0,corticosteroids,azathioprine,137-151,175-186,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p32,0,corticosteroids,chloroquine,137-151,189-199,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p33,0,corticosteroids,gold,137-151,202-205,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p34,0,corticosteroids,hydroxychloroquine,137-151,208-225,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p35,0,corticosteroids,leflunomide,137-151,228-238,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p36,0,corticosteroids,sulfasalazine,137-151,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p37,0,corticosteroids,anakinra,137-151,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p38,0,TNF blocking agents,azathioprine,154-172,175-186,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p39,0,TNF blocking agents,chloroquine,154-172,189-199,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p40,0,TNF blocking agents,gold,154-172,202-205,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p41,0,TNF blocking agents,hydroxychloroquine,154-172,208-225,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p42,0,TNF blocking agents,leflunomide,154-172,228-238,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p43,0,TNF blocking agents,sulfasalazine,154-172,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p44,0,TNF blocking agents,anakinra,154-172,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p45,0,azathioprine,chloroquine,175-186,189-199,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p46,0,azathioprine,gold,175-186,202-205,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p47,0,azathioprine,hydroxychloroquine,175-186,208-225,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p48,0,azathioprine,leflunomide,175-186,228-238,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p49,0,azathioprine,sulfasalazine,175-186,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p50,0,azathioprine,anakinra,175-186,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p51,0,chloroquine,gold,189-199,202-205,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p52,0,chloroquine,hydroxychloroquine,189-199,208-225,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p53,0,chloroquine,leflunomide,189-199,228-238,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p54,0,chloroquine,sulfasalazine,189-199,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p55,0,chloroquine,anakinra,189-199,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p56,0,gold,hydroxychloroquine,202-205,208-225,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p57,0,gold,leflunomide,202-205,228-238,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p58,0,gold,sulfasalazine,202-205,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p59,0,gold,anakinra,202-205,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p60,0,hydroxychloroquine,leflunomide,208-225,228-238,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p61,0,hydroxychloroquine,sulfasalazine,208-225,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p62,0,hydroxychloroquine,anakinra,208-225,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p63,0,leflunomide,sulfasalazine,228-238,241-253,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p64,0,leflunomide,anakinra,228-238,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s2,"The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.",DDI-DrugBank.d297.s2.p65,0,sulfasalazine,anakinra,241-253,260-267,"ORENCIA,MTX,NSAIDs,corticosteroids,TNF blocking agents,azathioprine,chloroquine,gold,hydroxychloroquine,leflunomide,sulfasalazine,anakinra,"
DDI-DrugBank.d297.s3,Concurrent administration of a TNF antagonist with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.,DDI-DrugBank.d297.s3.p0,1,TNF antagonist,ORENCIA,31-44,51-57,"TNF antagonist,ORENCIA,TNF antagonists,"
DDI-DrugBank.d297.s3,Concurrent administration of a TNF antagonist with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.,DDI-DrugBank.d297.s3.p1,0,TNF antagonist,TNF antagonists,31-44,179-193,"TNF antagonist,ORENCIA,TNF antagonists,"
DDI-DrugBank.d297.s3,Concurrent administration of a TNF antagonist with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.,DDI-DrugBank.d297.s3.p2,0,ORENCIA,TNF antagonists,51-57,179-193,"TNF antagonist,ORENCIA,TNF antagonists,"
DDI-DrugBank.d297.s4,Concurrent therapy with ORENCIA and TNF antagonists is not recommended.,DDI-DrugBank.d297.s4.p0,1,ORENCIA,TNF antagonists,24-30,36-50,"ORENCIA,TNF antagonists,"
DDI-DrugBank.d297.s5,"There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.",DDI-DrugBank.d297.s5.p0,1,ORENCIA,anakinra,70-76,109-116,"ORENCIA,anakinra,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p0,0,heparin,warfarin,32-38,41-48,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p1,0,heparin,beta-adrenergic receptor blockers,32-38,51-83,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p2,0,heparin,calcium channel antagonists,32-38,86-112,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p3,0,heparin,angiotensin converting enzyme inhibitors,32-38,115-154,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p4,0,heparin,nitrates,32-38,178-185,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p5,0,heparin,ticlopidine,32-38,188-198,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p6,0,heparin,aspirin,32-38,205-211,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p7,0,warfarin,beta-adrenergic receptor blockers,41-48,51-83,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p8,0,warfarin,calcium channel antagonists,41-48,86-112,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p9,0,warfarin,angiotensin converting enzyme inhibitors,41-48,115-154,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p10,0,warfarin,nitrates,41-48,178-185,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p11,0,warfarin,ticlopidine,41-48,188-198,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p12,0,warfarin,aspirin,41-48,205-211,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p13,0,beta-adrenergic receptor blockers,calcium channel antagonists,51-83,86-112,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p14,0,beta-adrenergic receptor blockers,angiotensin converting enzyme inhibitors,51-83,115-154,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p15,0,beta-adrenergic receptor blockers,nitrates,51-83,178-185,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p16,0,beta-adrenergic receptor blockers,ticlopidine,51-83,188-198,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p17,0,beta-adrenergic receptor blockers,aspirin,51-83,205-211,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p18,0,calcium channel antagonists,angiotensin converting enzyme inhibitors,86-112,115-154,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p19,0,calcium channel antagonists,nitrates,86-112,178-185,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p20,0,calcium channel antagonists,ticlopidine,86-112,188-198,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p21,0,calcium channel antagonists,aspirin,86-112,205-211,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p22,0,angiotensin converting enzyme inhibitors,nitrates,115-154,178-185,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p23,0,angiotensin converting enzyme inhibitors,ticlopidine,115-154,188-198,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p24,0,angiotensin converting enzyme inhibitors,aspirin,115-154,205-211,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p25,0,nitrates,ticlopidine,178-185,188-198,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p26,0,nitrates,aspirin,178-185,205-211,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s2,"These medications have included heparin, warfarin, beta-adrenergic receptor blockers, calcium channel antagonists, angiotensin converting enzyme inhibitors, intravenous and oral nitrates, ticlopidine, and aspirin.",DDI-DrugBank.d532.s2.p27,0,ticlopidine,aspirin,188-198,205-211,"heparin,warfarin,beta-adrenergic receptor blockers,calcium channel antagonists,angiotensin converting enzyme inhibitors,nitrates,ticlopidine,aspirin,"
DDI-DrugBank.d532.s3,"Heparin, other anticoagulants, thrombolytics, and anti platelet agents are associated with an increase in bleeding.",DDI-DrugBank.d532.s3.p0,0,Heparin,anticoagulants,0-6,15-28,"Heparin,anticoagulants,thrombolytics,anti platelet agents,"
DDI-DrugBank.d532.s3,"Heparin, other anticoagulants, thrombolytics, and anti platelet agents are associated with an increase in bleeding.",DDI-DrugBank.d532.s3.p1,0,Heparin,thrombolytics,0-6,31-43,"Heparin,anticoagulants,thrombolytics,anti platelet agents,"
DDI-DrugBank.d532.s3,"Heparin, other anticoagulants, thrombolytics, and anti platelet agents are associated with an increase in bleeding.",DDI-DrugBank.d532.s3.p2,0,Heparin,anti platelet agents,0-6,50-69,"Heparin,anticoagulants,thrombolytics,anti platelet agents,"
DDI-DrugBank.d532.s3,"Heparin, other anticoagulants, thrombolytics, and anti platelet agents are associated with an increase in bleeding.",DDI-DrugBank.d532.s3.p3,0,anticoagulants,thrombolytics,15-28,31-43,"Heparin,anticoagulants,thrombolytics,anti platelet agents,"
DDI-DrugBank.d532.s3,"Heparin, other anticoagulants, thrombolytics, and anti platelet agents are associated with an increase in bleeding.",DDI-DrugBank.d532.s3.p4,0,anticoagulants,anti platelet agents,15-28,50-69,"Heparin,anticoagulants,thrombolytics,anti platelet agents,"
DDI-DrugBank.d532.s3,"Heparin, other anticoagulants, thrombolytics, and anti platelet agents are associated with an increase in bleeding.",DDI-DrugBank.d532.s3.p5,0,thrombolytics,anti platelet agents,31-43,50-69,"Heparin,anticoagulants,thrombolytics,anti platelet agents,"
DDI-DrugBank.d532.s4,Patients with HACA titers might have allergic or hypersensitivity reactions when treated with other diagnostic or therapeutic monoclonal antibodies.,DDI-DrugBank.d532.s4.p0,0,diagnostic monoclonal antibodies,therapeutic monoclonal antibodies,98-107;124-144,112-144,"diagnostic monoclonal antibodies,therapeutic monoclonal antibodies,"
DDI-DrugBank.d0.s0,The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.,DDI-DrugBank.d0.s0.p0,0,alcohol,Acamprosate,26-32,38-48,"alcohol,Acamprosate,alcohol,acamprosate,"
DDI-DrugBank.d0.s0,The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.,DDI-DrugBank.d0.s0.p1,0,alcohol,alcohol,26-32,97-103,"alcohol,Acamprosate,alcohol,acamprosate,"
DDI-DrugBank.d0.s0,The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.,DDI-DrugBank.d0.s0.p2,0,alcohol,acamprosate,26-32,108-118,"alcohol,Acamprosate,alcohol,acamprosate,"
DDI-DrugBank.d0.s0,The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.,DDI-DrugBank.d0.s0.p3,0,Acamprosate,alcohol,38-48,97-103,"alcohol,Acamprosate,alcohol,acamprosate,"
DDI-DrugBank.d0.s0,The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.,DDI-DrugBank.d0.s0.p4,0,Acamprosate,acamprosate,38-48,108-118,"alcohol,Acamprosate,alcohol,acamprosate,"
DDI-DrugBank.d0.s0,The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate.,DDI-DrugBank.d0.s0.p5,0,alcohol,acamprosate,97-103,108-118,"alcohol,Acamprosate,alcohol,acamprosate,"
DDI-DrugBank.d0.s1,Pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate.,DDI-DrugBank.d0.s1.p0,0,disulfiram,diazepam,56-65,70-77,"disulfiram,diazepam,acamprosate,"
DDI-DrugBank.d0.s1,Pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate.,DDI-DrugBank.d0.s1.p1,0,disulfiram,acamprosate,56-65,119-129,"disulfiram,diazepam,acamprosate,"
DDI-DrugBank.d0.s1,Pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate.,DDI-DrugBank.d0.s1.p2,0,diazepam,acamprosate,70-77,119-129,"disulfiram,diazepam,acamprosate,"
DDI-DrugBank.d0.s2,Co-administration of naltrexone with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.,DDI-DrugBank.d0.s2.p0,1,naltrexone,Acamprosate,21-30,37-47,"naltrexone,Acamprosate,acamprosate,"
DDI-DrugBank.d0.s2,Co-administration of naltrexone with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.,DDI-DrugBank.d0.s2.p1,0,naltrexone,acamprosate,21-30,114-124,"naltrexone,Acamprosate,acamprosate,"
DDI-DrugBank.d0.s2,Co-administration of naltrexone with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.,DDI-DrugBank.d0.s2.p2,0,Acamprosate,acamprosate,37-47,114-124,"naltrexone,Acamprosate,acamprosate,"
DDI-DrugBank.d0.s4,The pharmacokinetics of naltrexone and its major metabolite 6-beta-naltrexol were unaffected following co-administration with Acamprosate.,DDI-DrugBank.d0.s4.p0,0,naltrexone,6-beta-naltrexol,24-33,60-75,"naltrexone,6-beta-naltrexol,Acamprosate,"
DDI-DrugBank.d0.s4,The pharmacokinetics of naltrexone and its major metabolite 6-beta-naltrexol were unaffected following co-administration with Acamprosate.,DDI-DrugBank.d0.s4.p1,0,naltrexone,Acamprosate,24-33,126-136,"naltrexone,6-beta-naltrexol,Acamprosate,"
DDI-DrugBank.d0.s4,The pharmacokinetics of naltrexone and its major metabolite 6-beta-naltrexol were unaffected following co-administration with Acamprosate.,DDI-DrugBank.d0.s4.p2,0,6-beta-naltrexol,Acamprosate,60-75,126-136,"naltrexone,6-beta-naltrexol,Acamprosate,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p0,0,Acamprosate,anxiolytics,93-103,124-134,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p1,0,Acamprosate,hypnotics,93-103,137-145,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p2,0,Acamprosate,sedatives,93-103,151-159,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p3,0,Acamprosate,benzodiazepines,93-103,172-186,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p4,0,Acamprosate,non-opioid analgesics,93-103,193-213,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p5,0,anxiolytics,hypnotics,124-134,137-145,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p6,0,anxiolytics,sedatives,124-134,151-159,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p7,0,anxiolytics,benzodiazepines,124-134,172-186,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p8,0,anxiolytics,non-opioid analgesics,124-134,193-213,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p9,0,hypnotics,sedatives,137-145,151-159,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p10,0,hypnotics,benzodiazepines,137-145,172-186,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p11,0,hypnotics,non-opioid analgesics,137-145,193-213,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p12,0,sedatives,benzodiazepines,151-159,172-186,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p13,0,sedatives,non-opioid analgesics,151-159,193-213,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s5,"Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.",DDI-DrugBank.d0.s5.p14,0,benzodiazepines,non-opioid analgesics,172-186,193-213,"Acamprosate,anxiolytics,hypnotics,sedatives,benzodiazepines,non-opioid analgesics,"
DDI-DrugBank.d0.s6,"Patients taking Acamprosate concomitantly with antidepressants more commonly reported both weight gain and weight loss, compared with patients taking either medication alone.",DDI-DrugBank.d0.s6.p0,1,Acamprosate,antidepressants,16-26,47-61,"Acamprosate,antidepressants,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p0,0,thiazides,diuretics,24-32,44-52,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p1,0,thiazides,corticosteroids,24-32,55-69,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p2,0,thiazides,phenothiazines,24-32,72-85,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p3,0,thiazides,thyroid products,24-32,88-103,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p4,0,thiazides,estrogens,24-32,106-114,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p5,0,thiazides,contraceptives,24-32,122-135,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p6,0,thiazides,phenytoin,24-32,138-146,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p7,0,thiazides,nicotinic acid,24-32,149-162,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p8,0,thiazides,sympathomimetics,24-32,165-180,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p9,0,thiazides,calcium channel-blocking drugs,24-32,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p10,0,thiazides,isoniazid,24-32,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p11,0,diuretics,corticosteroids,44-52,55-69,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p12,0,diuretics,phenothiazines,44-52,72-85,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p13,0,diuretics,thyroid products,44-52,88-103,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p14,0,diuretics,estrogens,44-52,106-114,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p15,0,diuretics,contraceptives,44-52,122-135,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p16,0,diuretics,phenytoin,44-52,138-146,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p17,0,diuretics,nicotinic acid,44-52,149-162,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p18,0,diuretics,sympathomimetics,44-52,165-180,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p19,0,diuretics,calcium channel-blocking drugs,44-52,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p20,0,diuretics,isoniazid,44-52,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p21,0,corticosteroids,phenothiazines,55-69,72-85,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p22,0,corticosteroids,thyroid products,55-69,88-103,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p23,0,corticosteroids,estrogens,55-69,106-114,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p24,0,corticosteroids,contraceptives,55-69,122-135,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p25,0,corticosteroids,phenytoin,55-69,138-146,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p26,0,corticosteroids,nicotinic acid,55-69,149-162,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p27,0,corticosteroids,sympathomimetics,55-69,165-180,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p28,0,corticosteroids,calcium channel-blocking drugs,55-69,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p29,0,corticosteroids,isoniazid,55-69,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p30,0,phenothiazines,thyroid products,72-85,88-103,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p31,0,phenothiazines,estrogens,72-85,106-114,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p32,0,phenothiazines,contraceptives,72-85,122-135,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p33,0,phenothiazines,phenytoin,72-85,138-146,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p34,0,phenothiazines,nicotinic acid,72-85,149-162,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p35,0,phenothiazines,sympathomimetics,72-85,165-180,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p36,0,phenothiazines,calcium channel-blocking drugs,72-85,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p37,0,phenothiazines,isoniazid,72-85,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p38,0,thyroid products,estrogens,88-103,106-114,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p39,0,thyroid products,contraceptives,88-103,122-135,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p40,0,thyroid products,phenytoin,88-103,138-146,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p41,0,thyroid products,nicotinic acid,88-103,149-162,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p42,0,thyroid products,sympathomimetics,88-103,165-180,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p43,0,thyroid products,calcium channel-blocking drugs,88-103,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p44,0,thyroid products,isoniazid,88-103,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p45,0,estrogens,contraceptives,106-114,122-135,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p46,0,estrogens,phenytoin,106-114,138-146,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p47,0,estrogens,nicotinic acid,106-114,149-162,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p48,0,estrogens,sympathomimetics,106-114,165-180,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p49,0,estrogens,calcium channel-blocking drugs,106-114,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p50,0,estrogens,isoniazid,106-114,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p51,0,contraceptives,phenytoin,122-135,138-146,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p52,0,contraceptives,nicotinic acid,122-135,149-162,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p53,0,contraceptives,sympathomimetics,122-135,165-180,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p54,0,contraceptives,calcium channel-blocking drugs,122-135,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p55,0,contraceptives,isoniazid,122-135,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p56,0,phenytoin,nicotinic acid,138-146,149-162,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p57,0,phenytoin,sympathomimetics,138-146,165-180,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p58,0,phenytoin,calcium channel-blocking drugs,138-146,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p59,0,phenytoin,isoniazid,138-146,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p60,0,nicotinic acid,sympathomimetics,149-162,165-180,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p61,0,nicotinic acid,calcium channel-blocking drugs,149-162,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p62,0,nicotinic acid,isoniazid,149-162,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p63,0,sympathomimetics,calcium channel-blocking drugs,165-180,183-212,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p64,0,sympathomimetics,isoniazid,165-180,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s1,"These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.",DDI-DrugBank.d536.s1.p65,0,calcium channel-blocking drugs,isoniazid,183-212,219-227,"thiazides,diuretics,corticosteroids,phenothiazines,thyroid products,estrogens,contraceptives,phenytoin,nicotinic acid,sympathomimetics,calcium channel-blocking drugs,isoniazid,"
DDI-DrugBank.d536.s3,"When such drugs are withdrawn from patients receiving Acarbose in combination with sulfonylureas or insulin, patients should be observed closely for any evidence of hypoglycemia.",DDI-DrugBank.d536.s3.p0,0,Acarbose,sulfonylureas,54-61,83-95,"Acarbose,sulfonylureas,insulin,"
DDI-DrugBank.d536.s3,"When such drugs are withdrawn from patients receiving Acarbose in combination with sulfonylureas or insulin, patients should be observed closely for any evidence of hypoglycemia.",DDI-DrugBank.d536.s3.p1,0,Acarbose,insulin,54-61,100-106,"Acarbose,sulfonylureas,insulin,"
DDI-DrugBank.d536.s3,"When such drugs are withdrawn from patients receiving Acarbose in combination with sulfonylureas or insulin, patients should be observed closely for any evidence of hypoglycemia.",DDI-DrugBank.d536.s3.p2,0,sulfonylureas,insulin,83-95,100-106,"Acarbose,sulfonylureas,insulin,"
DDI-DrugBank.d536.s4,"Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) might reduce the effect of Acarbose and should not be taken concomitantly.",DDI-DrugBank.d536.s4.p0,0,Intestinal adsorbents,charcoal,0-20,30-37,"Intestinal adsorbents,charcoal,digestive enzyme preparations,amylase,pancreatin,Acarbose,"
DDI-DrugBank.d536.s4,"Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) might reduce the effect of Acarbose and should not be taken concomitantly.",DDI-DrugBank.d536.s4.p1,0,Intestinal adsorbents,digestive enzyme preparations,0-20,44-72,"Intestinal adsorbents,charcoal,digestive enzyme preparations,amylase,pancreatin,Acarbose,"
DDI-DrugBank.d536.s4,"Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) might reduce the effect of Acarbose and should not be taken concomitantly.",DDI-DrugBank.d536.s4.p2,0,Intestinal adsorbents,amylase,0-20,124-130,"Intestinal adsorbents,charcoal,digestive enzyme preparations,amylase,pancreatin,Acarbose,"
DDI-DrugBank.d536.s4,"Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) might reduce the effect of Acarbose and should not be taken concomitantly.",DDI-DrugBank.d536.s4.p3,0,Intestinal adsorbents,pancreatin,0-20,133-142,"Intestinal adsorbents,charcoal,digestive enzyme preparations,amylase,pancreatin,Acarbose,"
DDI-DrugBank.d536.s4,"Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) might reduce the effect of Acarbose and should not be taken concomitantly.",DDI-DrugBank.d536.s4.p4,1,Intestinal adsorbents,Acarbose,0-20,170-177,"Intestinal adsorbents,charcoal,digestive enzyme preparations,amylase,pancreatin,Acarbose,"
DDI-DrugBank.d536.s4,"Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) might reduce the effect of Acarbose and should not be taken concomitantly.",DDI-DrugBank.d536.s4.p5,0,charcoal,digestive enzyme preparations,30-37,44-72,"Intestinal adsorbents,charcoal,digestive enzyme preparations,amylase,pancreatin,Acarbose,"
DDI-DrugBank.d536.s4,"Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) might reduce the effect of Acarbose and should not be taken concomitantly.",DDI-DrugBank.d536.s4.p6,0,charcoal,amylase,30-37,124-130,"Intestinal adsorbents,charcoal,digestive enzyme preparations,amylase,pancreatin,Acarbose,"
